. | Controls (n = 16) . | METSYN (n = 18) . | P Value . |
---|---|---|---|
Gender | F (10), M (6) | F (9), M (9) | NS |
Age | 43 ± 3 | 46 ± 3 | NS |
Body mass index, kg/m2 | 23 ± 0.5 | 35 ± 2b | <.001 |
Waist circumference, cm | <102 (M) | 135 ± 18 (M)a | <.01 |
<88 (F) | 109 ± 5 (F)a | <.01 | |
Systolic BP, mm Hg | 112 ± 2 | 131 ± 5b | <.001 |
BP medications | (8) | ||
Diastolic BP, mm Hg | 70 ± 2 | 78 ± 3a | <.01 |
Fasting blood glucose, mg/dL | 88 ± 2 | 98 ± 3b | <.005 |
Total cholesterol, mg/dL | 191 ± 10 | 196 ± 9 | NS |
LDL cholesterol, mg/dL | 123 ± 9 | 128 ± 8 | NS |
Statin treatment | (5) | ||
HDL cholesterol, mg/dL | 57 ± 3 | 46 ± 2a | <.01 |
HDL <40, M | (5) | ||
HDL <50, F | (5) | ||
Triglycerides, mg/dL | 70 ± 7 | 124 ± 10b | <.001 |
Baseline insulin, mU/L | 2.7 ± 0.5 | 11.3 ± 2.6b | <.001 |
Baseline FFAs, mEq/L | 0.68 ± 0.04 | 0.93 ± 0.06b | <.002 |
. | Controls (n = 16) . | METSYN (n = 18) . | P Value . |
---|---|---|---|
Gender | F (10), M (6) | F (9), M (9) | NS |
Age | 43 ± 3 | 46 ± 3 | NS |
Body mass index, kg/m2 | 23 ± 0.5 | 35 ± 2b | <.001 |
Waist circumference, cm | <102 (M) | 135 ± 18 (M)a | <.01 |
<88 (F) | 109 ± 5 (F)a | <.01 | |
Systolic BP, mm Hg | 112 ± 2 | 131 ± 5b | <.001 |
BP medications | (8) | ||
Diastolic BP, mm Hg | 70 ± 2 | 78 ± 3a | <.01 |
Fasting blood glucose, mg/dL | 88 ± 2 | 98 ± 3b | <.005 |
Total cholesterol, mg/dL | 191 ± 10 | 196 ± 9 | NS |
LDL cholesterol, mg/dL | 123 ± 9 | 128 ± 8 | NS |
Statin treatment | (5) | ||
HDL cholesterol, mg/dL | 57 ± 3 | 46 ± 2a | <.01 |
HDL <40, M | (5) | ||
HDL <50, F | (5) | ||
Triglycerides, mg/dL | 70 ± 7 | 124 ± 10b | <.001 |
Baseline insulin, mU/L | 2.7 ± 0.5 | 11.3 ± 2.6b | <.001 |
Baseline FFAs, mEq/L | 0.68 ± 0.04 | 0.93 ± 0.06b | <.002 |
. | Controls (n = 16) . | METSYN (n = 18) . | P Value . |
---|---|---|---|
Gender | F (10), M (6) | F (9), M (9) | NS |
Age | 43 ± 3 | 46 ± 3 | NS |
Body mass index, kg/m2 | 23 ± 0.5 | 35 ± 2b | <.001 |
Waist circumference, cm | <102 (M) | 135 ± 18 (M)a | <.01 |
<88 (F) | 109 ± 5 (F)a | <.01 | |
Systolic BP, mm Hg | 112 ± 2 | 131 ± 5b | <.001 |
BP medications | (8) | ||
Diastolic BP, mm Hg | 70 ± 2 | 78 ± 3a | <.01 |
Fasting blood glucose, mg/dL | 88 ± 2 | 98 ± 3b | <.005 |
Total cholesterol, mg/dL | 191 ± 10 | 196 ± 9 | NS |
LDL cholesterol, mg/dL | 123 ± 9 | 128 ± 8 | NS |
Statin treatment | (5) | ||
HDL cholesterol, mg/dL | 57 ± 3 | 46 ± 2a | <.01 |
HDL <40, M | (5) | ||
HDL <50, F | (5) | ||
Triglycerides, mg/dL | 70 ± 7 | 124 ± 10b | <.001 |
Baseline insulin, mU/L | 2.7 ± 0.5 | 11.3 ± 2.6b | <.001 |
Baseline FFAs, mEq/L | 0.68 ± 0.04 | 0.93 ± 0.06b | <.002 |
. | Controls (n = 16) . | METSYN (n = 18) . | P Value . |
---|---|---|---|
Gender | F (10), M (6) | F (9), M (9) | NS |
Age | 43 ± 3 | 46 ± 3 | NS |
Body mass index, kg/m2 | 23 ± 0.5 | 35 ± 2b | <.001 |
Waist circumference, cm | <102 (M) | 135 ± 18 (M)a | <.01 |
<88 (F) | 109 ± 5 (F)a | <.01 | |
Systolic BP, mm Hg | 112 ± 2 | 131 ± 5b | <.001 |
BP medications | (8) | ||
Diastolic BP, mm Hg | 70 ± 2 | 78 ± 3a | <.01 |
Fasting blood glucose, mg/dL | 88 ± 2 | 98 ± 3b | <.005 |
Total cholesterol, mg/dL | 191 ± 10 | 196 ± 9 | NS |
LDL cholesterol, mg/dL | 123 ± 9 | 128 ± 8 | NS |
Statin treatment | (5) | ||
HDL cholesterol, mg/dL | 57 ± 3 | 46 ± 2a | <.01 |
HDL <40, M | (5) | ||
HDL <50, F | (5) | ||
Triglycerides, mg/dL | 70 ± 7 | 124 ± 10b | <.001 |
Baseline insulin, mU/L | 2.7 ± 0.5 | 11.3 ± 2.6b | <.001 |
Baseline FFAs, mEq/L | 0.68 ± 0.04 | 0.93 ± 0.06b | <.002 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.